Skip to main content
TipRanks
Go Ultimate75% OFF

Tvardi Therapeutics (69C) Q1 2025 Earnings Report

1 Followers

DE:69C Q1 2025 EPS Results

Actual EPS
-EUR 2.93
Consensus EPS
-EUR 0.53
Beat/Miss
Missed by -EUR 2.40
One Year Ago EPS
-EUR 18.34

DE:69C Q1 2025 Revenue Results

Actual Revenue
EUR 2.34M
Expected Revenue
EUR 0
Beat/Miss
Beat by +EUR 2.34M
YoY Revenue Growth
+20.33%

Earnings Announcement Details

Quarter
Q1 2025
Date
05/13/2025
Time
After Close
Conference Call
Tuesday, May 13, 2025
DE:69C Upcoming Earnings

Tvardi Therapeutics's next earnings date is estimated for April 6, 2027, based on past reporting schedules.

Q1 2025 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q1 2025 Earnings Slide Deck

No slide deck is available for this earnings event.

Q1 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:69C Earnings History

DE:69C earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Apr 06, 20272026 (Q4)-0.42--0.66――
Nov 13, 20262026 (Q3)-0.52-0.44-0.5418.64% (+0.10)
Aug 14, 20262026 (Q2)-0.64-0.63-0.9131.00% (+0.28)
May 08, 20262026 (Q1)―--2.93―
Mar 31, 20262025 (Q4)-0.68-0.66-2.9377.33% (+2.26)
Nov 13, 20252025 (Q3)-0.91-0.54-7.4592.80% (+6.91)
Aug 14, 20252025 (Q2)-0.62-0.91-11.9892.41% (+11.07)
May 13, 20252025 (Q1)-0.53-2.93-18.3484.03% (+15.41)
Feb 26, 20252024 (Q4)―-1.53-6.4476.27% (+4.91)
Nov 04, 20242024 (Q3)-0.22-0.21-0.4756.15% (+0.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed